§ Mr. RedmondTo ask the Secretary of State for Health if he will commission a study into an extended access programme for 3TC1; and if he will make a statement. [39208]
§ Mr. HoramWe do not run extended access programmes in the United Kingdom but clinicians can approach manufacturers of unlicensed drugs, such as 3TC—lamivudine—to request permission to prescribe the drug for named patients.